BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3379102)

  • 1. Modulation of the epidermal growth factor receptor by brain-derived growth factor in Swiss mouse 3T3 cells.
    Huang SS; Lokeshwar VB; Huang JS
    J Cell Biochem; 1988 Mar; 36(3):209-21. PubMed ID: 3379102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
    Huang JS; Nishimura J; Huang SS; Deuel TF
    J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone attenuation of epidermal growth factor-induced mitogenesis.
    Wiepz GJ; Houtman JC; Cha D; Bertics PJ
    J Cell Physiol; 1997 Oct; 173(1):44-53. PubMed ID: 9326448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the transmodulated epidermal growth factor receptor by cholera toxin and the protein phosphatase inhibitor okadaic acid.
    Winston JT; Olashaw NE; Pledger WJ
    J Cell Biochem; 1991 Sep; 47(1):79-89. PubMed ID: 1658015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the epidermal growth factor receptor by mitogenic ligands: effects of bombesin and role of protein kinase C.
    Zachary I; Rozengurt E
    Cancer Surv; 1985; 4(4):729-65. PubMed ID: 3916643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1 and TNF transmodulate epidermal growth factor receptors by a protein kinase C-independent mechanism.
    Bird TA; Saklatvala J
    J Immunol; 1989 Jan; 142(1):126-33. PubMed ID: 2783320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of retinoic acid on the binding and mitogenic activity of epidermal growth factor.
    Jetten AM
    J Cell Physiol; 1982 Mar; 110(3):235-40. PubMed ID: 6282898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterologous regulation of the epidermal growth factor receptor by palytoxin, a non-12-O-tetradecanoylphorbol-13-acetate-type tumor promoter.
    Wattenberg EV; Fujiki H; Rosner MR
    Cancer Res; 1987 Sep; 47(17):4618-22. PubMed ID: 2887282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of EGF-receptors by phorbol ester in small intestinal crypt cells.
    Baliga BS; Borowitz SM; Barnard JA
    Biochem Int; 1990; 20(1):161-8. PubMed ID: 2328019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous regulation of EGF receptors in fibroblastic cells.
    Olashaw NE; Pledger WJ
    J Cell Biochem; 1987 Jun; 34(2):143-9. PubMed ID: 3496345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells.
    Castagnola J; MacLeod C; Sunada H; Mendelsohn J; Taetle R
    J Cell Physiol; 1987 Sep; 132(3):492-500. PubMed ID: 3498729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells.
    Colburn NH; Gindhart TD; Hegamyer GA; Blumberg PM; Delclos KB; Magun BE; Lockyer J
    Cancer Res; 1982 Aug; 42(8):3093-7. PubMed ID: 6284358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of phorbol esters on cell growth and epidermal growth factor receptor modulation in a human gastric carcinoma cell line TMK-1.
    Ochiai A; Yasui W; Kameda T; Takanashi A; Takekura N; Tahara E
    Hiroshima J Med Sci; 1989 Dec; 38(4):191-5. PubMed ID: 2637248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon alpha/beta modulation of growth-factor-stimulated mitogenicity in AKR-2B fibroblasts.
    Pietenpol JA; Howe PH; Cunningham MR; Leof EB
    J Cell Physiol; 1989 Dec; 141(3):453-60. PubMed ID: 2687295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous and heterologous mitogenic desensitization of Swiss 3T3 cells to phorbol esters and vasopressin: role of receptor and postreceptor steps.
    Collins MK; Rozengurt E
    J Cell Physiol; 1984 Feb; 118(2):133-42. PubMed ID: 6319436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
    Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
    J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC; Keiser JA
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of type alpha transforming growth factor receptors by a phorbol ester tumor promoter.
    Davis R; Like B; Massagué J
    J Cell Biochem; 1985; 27(1):23-30. PubMed ID: 2984222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the epidermal growth factor receptor by basic fibroblast growth factor.
    Maher PA
    J Cell Physiol; 1993 Feb; 154(2):350-8. PubMed ID: 8425916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
    Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.